6982-46-3

Basic information

• Product Name: Ethanethiol
• Synonyms: 2-broMoethanethiol
• CAS NO: 6982-46-3
• Molecular Formula: C2H6S
• Molecular Weight: 62.13404
• EINECS: -0
• Mol File: 6982-46-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 144.5°C at 760 mmHg
• Flash Point: 41.2°C
• Appearance: /
• Density: 1.588g/cm³
• Vapor Pressure: 6.39mmHg at 25°C
• Refractive Index: 1.518
• PKA: 9.21±0.10(Predicted)
• CAS DataBase Reference: Ethanethiol(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanethiol(6982-46-3)
• EPA Substance Registry System: Ethanethiol(6982-46-3)

Safety Data

• Hazardous Substances Data: 6982-46-3(Hazardous Substances Data)

Usage

General Description

Ethanethiol, also known as ethyl mercaptan, is a colorless, flammable gas with a strong, unpleasant odor similar to that of rotten eggs. It is a volatile organic compound that is commonly used as a warning odorant in natural gas, propane, and other fuel gases to alert individuals to potential leaks. Ethanethiol is also used as a chemical intermediate in the production of pesticides, plastics, and pharmaceuticals. It is highly toxic and can cause irritation to the eyes, skin, and respiratory system, as well as being a strong respiratory and eye irritant. Exposure to ethanethiol should be minimized, and proper protective equipment should be used when handling the chemical.

InChI:InChI=1/C2H5BrS/c3-1-2-4/h4H,1-2H2

Upstream product

• 420-12-2 thirane 
• 10035-10-6 hydrogen bromide 
• 60-24-2 2-hydroxyethanethiol 

Downstream Products

• 15788-71-3 4-propoxy-thiobenzoic acid S-(2-diethylamino-ethyl ester) 
• 19967-75-0 2-benzothiazol-3-yl-ethanethiol 
• 15788-79-1 4-butoxy-thiobenzoic acid S-(2-diethylamino-ethyl ester) 

Relevant articles and documents

Ionic liquid used for secondary battery, synthetic method and application

The invention provides an ionic liquid used for a secondary battery, a synthetic method and application. The ionic liquid used for the secondary battery is an ionic liquid containing a heteroatom sidechain, and a functional group with positive charges inside the ionic liquid is one of quaternary ammonium salt, imidazolium salt, pyrrole salt and pyridinium salt; Y inside the side chain is S, an alkyl chain with the length of C1 to C3 is arranged between Y and the functional group with the positive charges, and alcohol or benzyl of C1 to C3 is arranged on the side, away from the functional group with the positive charges, of Y; and a negative ion X- is one of Cl-, Br-, I-, BF4- and TFSI- (trifluoromethanesulfonimide). The structure adjustability of the ionic liquid is preferable, the chemical structure of the ionic liquid can be modulated through a substituent group according to requirements, the conductivity of the ionic liquid is more than 1 mS/cm, and the requirement of the novel secondary magnesium battery on the conductivity can be met; sulfydryl is introduced into the ionic liquid by adopting nucleophilic substitution, and the complex capacity of the synthetic ionic liquid containing the heteroatom side chain on magnesium is theoretically moderate, so that the cycle performance of the battery is preferable.

16-Ethers of fusidic acid derivatives

The present invention relates to a new series of fusidic acid derivatives, to salts and easily hydrolysable esters thereof, to the preparation of these compounds, and to pharmaceutical compositions containing the compounds. The new compounds have the general formula STR1 in which the C24-25 bond is a single or a double bond, and in which Q1 and Q2 stand for STR2 or oxygen; A stands for oxygen, sulphur or a sulfinyl radical; R1 stands for a straight or branched alkyl radical having from 1 to 8 carbon atoms, an alkenyl or alkynyl radical having from 2 to 6 carbon atoms, a cycloalkyl radical having from 3 to 7 carbon atoms in the alicyclic ring, an aryl or aralkyl radical, a heterocyclic radical having 5 or 6 ring atoms, and containing oxygen, sulphur or nitrogen atoms, and pharmaceutically acceptable salts and easily hydrolysable esters thereof. The compound of the present invention show interesting antimicrobial and pharmacokinetic properties. Thereby the compounds of the invention can be used in the treatment of bacterial infections in humans and animals.